On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

We're at a crossroads where an end to the epidemic is truly within reach. So what happens next?

Health experts warn new HIV preventive jab does not protect against other STIs, pregnancyHealth experts are welcoming the registration of a twice-yearly injection to prevent HIV, while warning that ...

Seahawks QB Sam Darnold said the time off helped the oblique injury he suffered early in the playoffs and he needs to manage ...

International criminal syndicates have been using Fiji as a transshipment point for drugs originating in Southeast Asia and ...

The coroner could not definitively rule that the anaphylaxis death of 15-year-old Max McKenzie was preventable, despite ...

The company is hoping that its accelerated R&D strategy and new launches will help offset the impact of upcoming patent ...

There is a persistent assumption that medical doctors are automatically equipped to make these decisions. They are not.

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...